| 000 | 01870 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516044506.0 | ||
| 264 | 0 | _c20111027 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1091-6490 | ||
| 024 | 7 |
_a10.1073/pnas.1104675108 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDiPatrizio, Nicholas V | |
| 245 | 0 | 0 |
_aEndocannabinoid signal in the gut controls dietary fat intake. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cAug 2011 |
||
| 300 |
_a12904-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAmidohydrolases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzyl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCannabinoid Receptor Modulators _xmetabolism |
| 650 | 0 | 4 |
_aDietary Fats _xadministration & dosage |
| 650 | 0 | 4 |
_aEating _xdrug effects |
| 650 | 0 | 4 | _aEndocannabinoids |
| 650 | 0 | 4 |
_aGastrointestinal Tract _xdrug effects |
| 650 | 0 | 4 |
_aIntestine, Small _xdrug effects |
| 650 | 0 | 4 |
_aLipids _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhospholipase D _xmetabolism |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRimonabant |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aVagotomy |
| 700 | 1 | _aAstarita, Giuseppe | |
| 700 | 1 | _aSchwartz, Gary | |
| 700 | 1 | _aLi, Xiaosong | |
| 700 | 1 | _aPiomelli, Daniele | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 108 _gno. 31 _gp. 12904-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.1104675108 _zAvailable from publisher's website |
| 999 |
_c20982711 _d20982711 |
||